61-year-old female with triple-negative breast cancer of the right

Frontiers IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer

Endi KRIPA, Sapienza University of Rome, Rome, la sapienza

Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis

Rubina TRIMBOLI, PhD Student, University of Milan, Milan, UNIMI, Department of Biomedical Sciences for Health

A Positive Outlook Amidst Triple Negative Breast Cancer – cCARE

Frontiers Neighborhood Social Determinants of Triple Negative Breast Cancer

Prognosis of Triple-Negative Breast Cancer Varies By Age - CancerConnect

Brief description of the different types of biomarkers and respective

Menopause and Breast Cancer: What's the Connection?

a 61-year-old woman with multicentric left breast cancer who required a

Triple-negative breast cancer: disease entity or title of convenience?

Triple-Negative Breast Cancer: What Crucial Information can Imaging Add to the Diagnosis, Treatment and Prognosis?